摘要
肾癌被确诊时一半已属晚期,失去了手术机会。常规化疗、放疗及内分泌激素治疗效果较差。肿瘤的分子靶向治疗是近年来最具活力、备受关注的领域,其在肿瘤中的治疗已取得显著进展。本文对晚期肾癌分子靶向治疗新进展进行简要阐述。
Nearly half of renal carcinomas are confirmed, in its advanced stage and lost the thus become unsectable. Routine chemotherapy, radiotherapy, and hormonal therapy show poor efficacies. In recent years, molecularly targeted therapy in tumor showed promising future. Molecularly targeted therapy has achieved significant advances in tumor therapy. In this article, the author made a rewiew based on the latest research on molecularly targeted therapy for advanced renal carcinoma.
出处
《癌症进展》
2007年第4期333-337,345,共6页
Oncology Progress
关键词
肾癌
分子靶向治疗
renal carcinoma molecularly targeted therapy
